Injection Pen Market Projected to Hit USD 73.7 Billion by 2031, Driven by Steady CAGR of 7.2% - Transparency Market Research

The global injection pen market was valued at USD 39.8 billion in 2022 and is projected to grow at a CAGR of 7.2% from 2023 to 2031, reaching USD 73.7 billion by the end of 2031.

The rising prevalence of diabetes and the increasing preference for self-administration of medications are key factors driving the expansion of the injection pen market. Advanced injection pens with audible and visual feedback for dose confirmation are gaining popularity among end-users.

Gain a preview of important insights from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46446

Technological advancements have improved patient comfort and injection efficiency. Manufacturers are focusing on ease of cartridge replacement, precision dose settings, and enhanced usability, which are expected to enhance product performance and drive market growth.

Market Introduction

Injection pens are widely used medical devices that facilitate convenient and accurate drug delivery compared to traditional vials and syringes. These devices are commonly used for treating diabetes, rheumatoid arthritis, obesity, and insulin deficiency.

The market features two primary types of injection pens:

Disposable Pens: Pre-filled with insulin cartridges and discarded after use.

Reusable Pens: Feature a replaceable insulin cartridge that allows multiple uses.

These pens provide a user-friendly alternative to syringes, improving medication adherence and patient experience.

Market Drivers

High Prevalence of Diabetes
Injection pens are a preferred choice for insulin administration, with over 50% of diabetic patients using them for daily injections. According to the OECD (2019), one in three adults in the UK is obese, contributing to increased diabetes prevalence and insulin dependence.

Furthermore, pharmaceutical companies are introducing color-coded pens to reduce errors in selecting the correct insulin formulation. New drug approvals, such as Eli Lilly's Mounjaro (2024) for obesity and diabetes, are expected to further boost demand for injection pens.

Increasing Preference for Self-Administration
Injection pens make self-administration easier and less painful for patients. Their high precision and ease of use allow for more accurate insulin dosing, reducing the need for frequent clinical visits.

Durable, pre-filled, and interchangeable cartridge designs provide greater flexibility for patients, making them a preferred choice over traditional syringes. This trend is expected to continue during the forecast period as manufacturers introduce more user-friendly features.

High Demand for Disposable Injection Pens
Disposable injection pens accounted for a significant market share in 2022 due to their convenience and accurate dosing. These pens offer multiple doses with reduced infection risk, making them safer and more reliable than reusable options.

Visit our report to explore the detailed insights and key takeaways -

https://www.transparencymarketresearch.com/injection-pen-market.html

Regional Outlook

North America Leads Market Growth

North America dominated the injection pen market in 2022, driven by:

Increasing diabetes prevalence

Growing adoption of self-administration devices in home care settings

Presence of key industry players, such as Lilly, Novo Nordisk, and Sanofi

The strong presence of pharmaceutical giants and the rising demand for injectable therapies for diabetes, autoimmune diseases, and growth hormone disorders further boost the region's market expansion.

Competitive Landscape: Key Players and Market Strategies

Leading injection pen manufacturers are focusing on product design innovations, expanding regional presence, and improving accessibility through outsourcing services.

Civica, Inc. partnered with Ypsomed AG in 2023 to manufacture insulin injector pens for affordable insulin distribution.

Lilly and Novo Nordisk are launching new self-administration products to meet the rising demand for diabetes and obesity management.

Key Players in the Injection Pen Market

Lilly

Novo Nordisk

Owen Mumford

Sanofi

Hoffman-La Roche Ltd.
Merck KGaA

Haselmeier

Gerresheimer AG

BD

AstraZeneca

Recent Market Developments

January 2024: Lilly launched a direct-order website for its diabetes and weight-loss drug Zepbound, providing telehealth connectivity for obesity patients.

2023: Novo Nordisk introduced its weight-loss injection Wegovy in Britain, aiming to expand its European market presence.

Market Segmentation

By Type: Reusable, Disposable

By Indication: Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

By Region: North America (U.S., Canada), Europe (Germany, U.K., France, Italy, Spain, Russia & CIS), Asia Pacific (China, India, Japan, ASEAN), Latin America (Brazil, Mexico), Middle East & Africa (South Africa)

Buy this Premium Research Report for exclusive, in-depth insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=46446

Frequently Asked Questions (FAQs)

What is driving the growth of the injection pen market?
The market is primarily driven by the rising prevalence of diabetes, increasing adoption of self-administration devices, and advancements in injection pen technology.

What are the key trends in the injection pen market?
Some key trends include:

Integration of visual and audible feedback for accurate dosing

Development of pain-free injection technologies

Growing demand for disposable injection pens for convenience and safety

Which region holds the largest market share?
North America dominated the market in 2022 due to the high prevalence of diabetes, strong presence of industry players, and increasing use of injection pens in home care settings.

What are the advantages of injection pens over traditional syringes?
Injection pens offer several benefits, including:

Easier self-administration

More precise dosing

Reduced injection pain

Lower risk of dosage errors

Who are the leading players in the injection pen industry?
Major companies include Lilly, Novo Nordisk, Sanofi, BD, AstraZeneca, and Merck KGaA, among others. These companies are investing in research and product innovations to improve injection pen technology.

What is the market forecast for injection pens by 2031?
The injection pen market is projected to reach USD 73.7 billion by 2031, growing at a CAGR of 7.2% from 2023 to 2031.

Are reusable or disposable injection pens more popular?
While both types are widely used, disposable injection pens are gaining more traction due to their convenience, pre-filled medications, and reduced infection risks.

How is technology improving injection pens?
Innovations such as smart insulin pens, ergonomic designs, dose memory tracking, and painless injection technology are making injection pens more effective and user-friendly.

Explore Latest Research Reports by Transparency Market Research:

Endoscopic Stricture Management Device Market - https://www.transparencymarketresearch.com/endoscopic-stricture-management-device-market.html

Flowable Hemostats Market - https://www.transparencymarketresearch.com/flowable-hemostats-market.html

Hormonal Contraceptive Market - https://www.transparencymarketresearch.com/hormonal-contraceptives-market.html

Neuroscience Market - https://www.transparencymarketresearch.com/neuroscience-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.